X

Articles

23Jul

CTS conversion to the Ortho VERSEIA Integrated Processor (VIP) in January 2021

0 Comments | | Return |

After a thorough and comprehensive review of proposals received from suppliers of viral marker testing platforms and assays, CTS has decided to convert to the Ortho VERSEIA Integrated Processor (VIP) viral marker testing platform and associated assays in January 2021. An exact conversion date will be provided when available. We are confident that the VERSIA system will allow us to continue delivering on our commitment to support our clients in their life-saving mission.

Read all about it on the Communication page by clicking this link: Communications

Related

CTS exhibiting at AABB in San Antonio this weekend!

As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...

Read More >

Reminder- Check flights and cargo hours for the Christmas holiday

As a friendly reminder, airlines often change their routine flights and cargo hours for hol...

Read More >

The Reentry Changes Q & A document is now available

The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...

Read More >

Renewed NYSDOH licenses now available on the website

As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....

Read More >

Reminder- ZIKV Testing Strategy Webinar Wednesday 8/15/18

Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...

Read More >

Reminder- Check flights and cargo hours for the Labor Day Holiday

As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...

Read More >

Subscribe here to receive CTS updates!

Name